Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program.
about
Using computerized data to identify adverse drug events in outpatients.The natural history of histologically proved drug induced liver disease.Polypharmacy in the HIV-infected older adult population.Questionable prescribing for elderly patients in Quebec.Drug related admissions to medical wards: a population based survey.Hospital admissions resulting from preventable adverse drug reactions.Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?Adverse drug reaction reporting in New Zealand: implications for pharmacistsComputerized surveillance of adverse drug events in hospital patients. 1991Saskatchewan dial-access drug information service.The prevention of adverse drug reactions--a potential role for pharmacists in the primary care team?Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signalsClinical pharmacy interventions by community pharmacists during the dispensing process.Towards the safer use of medicines.Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions.Drug-related hospital admissions.Drug use in a geriatric population.Comparison of two recently published algorithms for assessing the probability of adverse drug reactions.Difficulties in assessing the adverse effects of drugs.Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs.Adverse tissue reactions to drugs: a five-year surveillance study.Adverse drug reaction monitoring in Kuwait (1981-1984).Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong.Drug-induced illness as a cause for admission to a community hospital.Cost-Benefit Analysis of an Automated Pharmacy System.Critical analysis of the content and enforcement of mandatory consultation and patient profile laws.Improving Drug Prescribing in Primary Care: A Critical Analysis of the Experimental Literature.Teaching healthcare professionals about drug-induced disease: an innovative clinical therapeutic approach.Drug Information Centres: New Role for Pharmacists?
P2860
Q30650277-F10A848C-AEEF-42BA-B9E7-87DF5CE0FEE1Q33594865-6C0E13C8-C64A-4EDE-BFAE-FE9514CB021CQ34037407-559BD23A-B4C5-4C16-ACFE-3267A8BC361BQ34276987-170D133E-9EAD-424F-A46B-3ACF92FD1F88Q34402554-28A56657-99F7-439D-801E-D4A7D6E50A57Q34796945-0779E3FF-0BE1-48FC-BD49-EDC63FAABA8AQ34989875-9BBEF79B-0E34-493C-B373-1BDDDD243769Q35166718-386D1EB9-08C2-43F8-98F2-731FEA7A8E0CQ35527674-AE86DB4D-E059-44CB-896E-1B3F1C9D9D14Q35814992-2219137B-3A86-4AD5-A917-9527B340CED0Q35983765-CA20A7D7-B657-403C-B5CC-CF9F34A4DFCCQ36053234-08903632-871A-4732-B1B2-8BC550B9E4B0Q36053445-F85F5BCC-8E61-4FBA-9C60-304721612B7EQ36905230-42A0714C-CB1B-4AE5-AA53-0B3B2E21DE80Q39627241-46DAD159-516A-43C0-86F8-0FC40FC1810FQ40842331-B69786DD-65AE-4DA9-B6B7-68DF7C255CD1Q41688728-F7F48943-EF8E-405B-A6BC-BFCC0C034055Q41896463-62D3F130-3676-4D91-AD45-5B4FF5CFE1EAQ42223127-833A76AD-329B-4853-B4EE-42439A45E1DFQ42261959-E9568E3E-D96C-45AD-A636-0CC76438E0B4Q44626738-78591C43-6536-4605-84F5-B79C4C014E66Q44769762-20598475-B4CA-42E4-8FD5-9A6D87DA339CQ44897784-FDDE5EAF-A988-4E5C-BD60-722D6CAB2A6DQ44963457-209C8861-7FB3-424C-8248-447229E46ABDQ45779535-E1D31C9C-490F-4500-B475-BB10C12D31E8Q46129626-678115C8-8568-45EB-9B55-26A65AC2A057Q46982709-31FC8783-FB7B-4603-B51D-0C546A6C361CQ52201750-49A3BA8B-5CD3-4174-BDC1-04B72B8406C5Q57386618-62F8903B-C847-4A75-9F04-100999EDF871
P2860
Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh
1974年學術文章
@zh-hant
name
Hospital admissions due to adv ...... ive Drug Surveillance Program.
@en
Hospital admissions due to adv ...... ive Drug Surveillance Program.
@nl
type
label
Hospital admissions due to adv ...... ive Drug Surveillance Program.
@en
Hospital admissions due to adv ...... ive Drug Surveillance Program.
@nl
prefLabel
Hospital admissions due to adv ...... ive Drug Surveillance Program.
@en
Hospital admissions due to adv ...... ive Drug Surveillance Program.
@nl
P1476
Hospital admissions due to adv ...... ive Drug Surveillance Program.
@en
P2093
P304
P356
10.1001/ARCHINTE.1974.00320200029002
P407
P577
1974-08-01T00:00:00Z